Context Therapeutics
Price & Volume
Stats
See more52W Range | $0.49-$2.58 |
Market Cap | $125.5M |
Shares Short | 493,155 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • 5 days ago
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Yahoo Finance • 7 days ago
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Context Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 2 months ago
CONTEXT THERAPEUTICS INC (NASDAQ:CNTX) Posts Wider Q2 2025 Loss Amid Continued Pipeline Progress
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
